Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-25T06:51:42.028Z Has data issue: false hasContentIssue false
  • English
  • Français

Increasing Bacteremia Due to Coagulase-Negative Staphylococci: Fiction or Reality?

Published online by Cambridge University Press:  02 January 2015

Joakim D. Thylefors ,
Stephan Harbarth  and
Didier Pittet
Joakim D. Thylefors
Affiliation:
Infection Control Program, the University of Geneva Hospitals, Geneva, Switzerland
Stephan Harbarth
Affiliation:
Infection Control Program, the University of Geneva Hospitals, Geneva, Switzerland
Didier Pittet*
Affiliation:
Infection Control Program, the University of Geneva Hospitals, Geneva, Switzerland
*
Infection Control Program, Department of Internal Medicine, The University of Geneva Hospitals, 1211 Geneva 14, Switzerland; e-mail, Didier.Pittet@hcuge.ch
Get access Rights & Permissions [Opens in a new window]

Abstract

BACKGROUND:

The role of coagulase-negative staphylococci (CNS) in bacteremias continues to be controversial. Until the 1970s, CNS were mostly recognized as contaminants, being part of the cutaneous flora. Since then, several studies have reported increasing incidence and severity of infections due to CNS.

PURPOSE:

To review the literature concerning the epidemiology of CNS bacteremia in the United States and Europe with reference to the multiple definitions of infection versus contamination, considering the effect of potential biases influencing the validity of the reported results.

METHODS:

Literature search of the MEDLINE database from January 1980 to February 1998. Studies with fewer than 500 episodes of bloodstream infections or fewer than 100 episodes of CNS bacteremia were not included in the pooled analysis.

RESULTS:

(1) CNS remain the most frequent contaminants (58%-83% of positive blood cultures); (2) the proportion of all bloodstream infections caused by CNS is increasing (R=.51); (3) the overall incidence of true CNS bacteremia is increasing (R=.54, P=.0014); (4) comparing the United States to Europe, there is an increasing trend in the incidence of nosocomial bacteremia due to CNS in the United States (R=.82, P=.0006), but no trend is seen in European studies; (5) the mortality associated with true CNS bacteremia varies between 4.9% and 28%.

DISCUSSION:

This review confirms the increasing importance of CNS bacteremias, measured both as a proportion and as an incidence of bloodstream infections. The contributions of several possible explanations for the incidence increase and the difference between the United States and Europe need further evaluation: (1) increased recognition and awareness of CNS infections among clinicians; (2) a gradual change in the definition of true bacteremia from an obligatory two positive blood cultures to one positive blood culture associated with a clinical picture compatible with infection; (3) a change in blood culture practices and techniques; (4) an increase in the numbers of blood cultures performed, which is reported both in the United States and in Europe; (5) a shift toward more elderly patients with increasingly severe underlying illnesses; and (6) increasing use of intravascular devices.

CONCLUSIONS:

The apparent trend of increasing CNS bacteremia seems to be valid. Whether there is a real difference between the United States and Europe concerning the increase of CNS bacteremia is difficult to establish due to the large number of confounding factors. Few studies take into account the number of blood cultures performed or the use of intravascular devices to adjust for the observed trends. Further on-site surveillance studies are needed to investigate the phenomenon more extensively.

Type
From the Fifth International Conference on the Prevention of Infection
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 8 , August 1998 , pp. 581 - 589
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Boyce, JM. Coagulase-negative staphylococci. In Mayhall, G, ed. Hospital Epidemiology and Infection Control; Baltimore, MD: Williams & Wilkins; 1996:306–325.Google Scholar
2.McGowan, JE Jr.Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Rev Infect Dis 1985;7(suppl 3):S357–S370.Google Scholar
3.Morrison, AJ Jr, Freer, CV, Searcy, MA, Landry, SM, Wenzel, RP. Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control 1986;7:550–553.Google Scholar
4.Banerjee, SN, Emori, TG, Culver, DH, Gaynes, RP, Jarvis, WR, Horan, TC, et al.Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91:86S–89S.Google Scholar
5.Scheckler, WE, Scheibel, W, Kresge, D. Temporal trends in septicemia in a community hospital. Am J Med 1991;91:90S–94S.Google Scholar
6.Pittet, D, Wenzel, RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177–1184.Google Scholar
7.Geerdes, HF, Ziegler, D, Lode, H, Hund, M, Loehr, A, Fangmann, W, et al.Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 1992;15:991–1002.Google Scholar
8.Iversen, G, Scheel, O. Epidemiological aspects of community-acquired and hospital-acquired bacteremia in northern Norway. Scand J Infect Dis 1993;25:465–470.Google Scholar
9.Haug, JB, Harthug, S, Kalager, T, Digranes, A, Solberg, CO. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 1994;19:246–256.Google Scholar
10.Arpi, M, Renneberg, J, Andersen, HK, Nielsen, B, Larsen, SO. Bacteremia at a Danish university hospital during a twenty-five-year period (19681992). Scand J Infect Dis 1995;27:245–251.Google Scholar
11.Eykyn, SJ, Gransden, WR, Phillips, I. The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother 1990;25(suppl C):41–58.Google Scholar
12.Rupp, ME, Archer, GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 1994;19:231–245.Google Scholar
13.Lew, DP, Pittet, D, Waldvogel, FA. Infections that complicate the insertion of prosthetic devices. In: Mayhall, G, ed. Hospital Epidemiology and Infection Control; Baltimore, MD: Williams & Wilklins; 1995:731–748.Google Scholar
14.Weinstein, MP, Towns, ML, Quartey, SM, Mirrett, S, Reimer, LG, Parmigiani G, et al.The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584–602.Google Scholar
15.Jarvis, WR, Edwards, JR, Culver, DH, Hughes, JM, Horan, T, Emori, TG, et al.Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991;91:185S–191S.Google Scholar
16.Cockerill, FR, Hughes, JG, Vetter, EA, Mueller, RA, Weaver, AL, Ilstrup, DM, et al.Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 1997;24:403–418.Google Scholar
17.Roberts, FJ, Geere, IW, Coldman, A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991;13:34–46.Google Scholar
18.Martin, MA, Pfaller, MA, Wenzel, RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:9–16.Google Scholar
19.Stillman, RI, Wenzel, RP, Donowitz, LC. Emergence of coagulase negative staphylococci as major nosocomial bloodstream pathogens. Infect Control 1987;8:108–112.Google Scholar
20.Kirchhoff, LV, Sheagren, JN. Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect Control 1985;6:479–486.Google Scholar
21.Weinstein, MP, Reller, LB, Murphy, JR, Lichtenstein, KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults, I: laboratory and epidemiologic observations. Rev Infect Dis 1983;5:35–53.Google Scholar
22.Jensen, AG, Kirstein, A, Jensen, I, Scheibel, J, Espersen, F. A 6-month prospective study of hospital-acquired bacteremia in Copenhagen county. Scand J Infect Dis 1996;28:601–608.Google Scholar
23.Rubio, M, Palau, L, Vivas, JR, del Potro, E, Diaz Mediavilla, J, Alvarez, A, et al.Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 1994;15:101–104.Google Scholar
24.Gatell, JM, Trilla, A, Latorre, X, Almela, M, Mensa, J, Moreno, A, et al.Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 1988;10:203–210.Google Scholar
25.Elhanan, G, Raz, R, Pitlik, SD, Sharir, R, Konisberger, H, Samra, Z, et al.Bacteraemia in a community and a university hospital. J Antimicrob Chemother 1995;36:681–695.Google Scholar
26.Leibovici, L, Gransden, WR, Eykyn, SJ, Konisberger, H, Drucker, M, Pitlik, SD, et al.Clinical index to predict bacteraemia caused by staphylococci. J Intern Med 1993;234:83–89.Google Scholar
27.Maniatis, AN, Trougakos, IP, Katsanis, G, Palermos, J, Maniatis, NA, Legakis, NJ. Changing patterns of bacterial nosocomial infections: a nine-year study in a general hospital. Chemotherapy 1997;43:69–76.Google Scholar
28.Rosenthal, EJ. The epidemiology of septicemia causative agents. A blood culture study of the Paul Ehrlich Society for Chemotherapy. Dtsch Med Wochenschr 1993;118:1269–1275.Google Scholar
29.Dornbusch, K, the European Study Group on Antibiotic Resistance. Resistance to β-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. J Antimicrob Chemother 1990;26:269–278.Google Scholar
30.French, GL, Cheng, AF, Duthie, R, Cockram, CS. Septicaemia in Hong Kong. J Antimicrob Chemother 1990;25(suppl C):115–125.Google Scholar
31.Vazquez, F, Mendoza, MC, Villar, MH, Perez, F, Mendez, FJ. Survey of bac-teraemia in a Spanish hospital over a decade (1981-1990). J Hosp Infect 1994;26:111–121.Google Scholar
32.Müller, F, Hund, M, Lohr, J, Lode, H, Wagner, J, Fangmann, W. Infection 1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in 691 patients. Med Klin 1989;84:323–328.Google Scholar
33.Ispahani, P, Pearson, NJ, Greenwood, D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. QJM 1987;63:427–440.Google Scholar
34.Bruun, B, Sloth, K, Bentzon, MW, Frederiksen, W. A study of bacteremias in Denmark from 1977-1978. APMIS [B] 1982;90:309–317.Google Scholar
35.Michel, MF, Priem, CC. Positive blood cultures in a university hospital in the Netherlands. Infection 1981;9:283–289.Google Scholar
36.Fidalgo, S, Vazquez, F, Mendoza, MC, Përez, F, Mëndez, FJ. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis 1990;12:520–528.Google Scholar
37.Källman, J, Kihlström, E, Sjöberg, L, Schollin, J. Increase of staphylococci in neonatal septicaemia: a fourteen-year study. Acta Paediatr 1997;86:533–538.Google Scholar
38.Righter, J. Septicemia due to coagulase-negative Staphylococcus in a community hospital. Can Med Assoc J 1987;137:121–125.Google Scholar
39.Pittet, D, Harbarth, S. The intensive care unit. In: Bennett, JV, Brachman, PS, eds. Hospital Infections. Boston, MA: Little, Brown and Co; 1998:381–402.Google Scholar
40.Pittet, D. Nosocomial bloodstream infections. In Wenzel, RP, ed. Prevention and Control of Nosocomial Infections. Baltimore, MD: Williams & Wilkins; 1997:712–769.Google Scholar
41.Hospital Infection Program, Centers for Disease Control and Prevention, Public Health Service; US Department of Health and Human Services. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1997. Am J Infect Control 1997;25:477–487.Google Scholar
42.Valles, J, Leon, C, Alvarez-Lerma, F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish collaborative group for infections in intensive care units. Clin Infect Dis 1997;24:387–395.Google Scholar
43.Rello, J, Ricart, M, Mirelis, B, Quintana, E, Gurgui, M, Net, A, et al.Nosocomial bacteremia in a medical-surgical intensive care unit: epidemio-logic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994;20:94–98.Google Scholar
44.Beck-Sague, CM, Azimi, P, Fonseca, SN, Baltimore, RS, Powell, DA, Bland, LA, et al.Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J 1994;13:1110–1116.Google Scholar
45.Gaynes, RP, Edwards, JR, Jarvis, WR, Culver, DH, Tolson, JS, Martone, WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996;98:357–361.Google Scholar
46.Gray, JE, Richardson, DK, McCormick, MC, Goldmann, DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995;95:225–230.Google Scholar
47.Gransden, WR, Eykyn, SJ, Phillips, I. Septicaemia in the newborn and elderly. J Antimicrob Chemother 1994;34(suppl A):101–119.Google Scholar
48.Faxelius, G, Ringertz, S. Neonatal septicemia in Stockholm. Eur J Clin Microbiol Infect Dis 1987;6:262–265.Google Scholar
49.Ljungman, P, Malmborg, AS, Nyström, B, Tillegard, A. Bacteremia in a Swedish university hospital: a one-year prospective study in 1981 and a comparison with 1975-76. Infection 1984;12:243–247.Google Scholar
50.Pittet, D, Li, N, Woolson, RF, Wenzel, RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections. A six year validated, population-based model. Clin Infect Dis 1997;24:1068–1078.Google Scholar
51.Ponce de Leon, S, Wenzel, RP. Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Am J Med 1984;77:639–644.Google Scholar
52.Herwaldt, LA, Geiss, M, Kao, C, Pfaller, MA. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 1996;22:14–20.Google Scholar
53.Dominguez-de Villota, E, Algora-Weber, A, Millian, I, Rubio, JJ, Galdos, P, Mosquera, JM. Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients. A clinically uncertain judgement. Intensive Care Med 1987;13:390–394.Google Scholar
54.Chandrasekar, PH, Brown, WJ. Clinical issues of blood cultures. Arch Intern Med 1994;154:841–849.Google Scholar
55.Mermel, LA, Maki, DG: Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993;119:270–272.Google Scholar
56.Weinstein, MP, Mirrett, S, Wilson, ML, Reimer, LG, Reller, LB. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic bact/alert blood culture bottles. J Clin Microbiol 1994;32:2103–2106.Google Scholar
57.Haley, RW, Culver, DH, Morgan, WM, White, JW, Emori, TG, Hooton, TM. Increased recognition of infectious diseases in US hospitals through increased use of diagnostic tests, 1970-1976. Am J Epidemiol 1985;121:168–181.Google Scholar
58.Harbarth, S, Rohner, P, Auckenthaler, R, Safran, E, Sudre, P, Pittet, D. Gramnegative bacteremia: Incidence, antimicrobial resistance and impact at a large teaching hospital. The Eighth Society for Healthcare Epidemiology Annual Meeting; Orlando, FL; 04 5, 1998. Abstract 25.Google Scholar
59.Pittet, D, Thiévent, B, Wenzel, RP, Li, N, Gurman, G, Suter, PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993;19:265–272.Google Scholar
60.Leibovici, L, Pitlik, SD, Konisberger, H, Drucker, M. Bloodstream infections in patients older than eighty years. Age Ageing 1993;22:431–442.Google Scholar
61.Perl, TM, Dvorak, L, Hwang, T, Wenzel, RP. Long-term survival and function after suspected gram-negative sepsis. JAMA 1995;274:338–345.Google Scholar
62.Olhsson, K, Bjsrk, P, Bergenfeldt, M, Hageman, R, Thompson, RC. Inter-leukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550–552.Google Scholar
63.Emori, TG, Banerjee, SN, Culver, DH, Gaynes, RP, Horan, TC, Edwards, JR, et al.Nosocomial infections in elderly patients in the United States, 1986-1990. National Nosocomial Infections Surveillance System. Am J Med 1991;91:289S–293S.Google Scholar
64.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.Google Scholar
65.Hirakata, Y, Furuya, N, Iwata, M, Kashitani, F, Ishikawa, M, Yumoto, S, et al.Assessment of clinical significance of positive blood cultures of relatively low-virulence isolates. J Med Microbiol 1996;44:195–198.Google Scholar
66.Nataro, JP, Corcoran, L, Zirin, S, Swink, S, Taichman, N, Goin, J, et al.Prospective analysis of coagulase-negative staphylococcal infection in hospitalized infants. J Pediatr 1994;125:798–804.Google Scholar
67.Vincent, JL, Bihari, DJ, Suter, PM, Bruining, HA, White, J, Nicolas-Chanoin, M-H, et al.The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274:639–644.Google Scholar
68.Rüden, H, Gastmeier, P, Daschner, F, Schumacher, M. Nosocomial infections in Germany. Their epidemiology in old and new Federal Länder. Dtsch Med Wochenschr 1996;121:1281–1287.Google Scholar
69.Raad, I, Darouiche, R. Prevention of infections associated with intravascular devices. Current Opinion in Critical Care 1996;2:361–365.Google Scholar
70.Centers for Disease Control. Increase in national hospital discharge survey rates for septicemia—United States, 1979-1987. MMWR 1990;39:31–34.Google Scholar
71.Maki, DG, Mermel, LA. Infections due to infusion therapy. In: Bennett, JV, Brachman, PS, eds. Hospital Infections. Philadelphia, PA: LippincottRaven; 1998:689–724.Google Scholar
72.Widmer, AF: Intravenous-related infections. In: Wenzel, RP, ed. Prevention and Control of Nosocomial Infections. Baltimore, MD: Williams & Wilkins; 1997:771–805.Google Scholar
73.Garner, JS, Jarvis, WR, Emori, TG, Toran, TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.Google Scholar
74.Jarvis, WR, Martone, WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29(suppl A):19–24.Google Scholar
75.Sage, R, Nazareth, B, Noone, P. A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis. Scand J Infect Dis 1987;19:331–337.Google Scholar